跳至主要内容
临床试验/NCT04787861
NCT04787861已完成不适用

Improved Pulmonary Functions and Exercise Capacity in Children With Down Syndrome Following Motorized Movement Therapy: Comparison With Chest Physical Therapy

Taibah University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年12月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Change from baseline in forced expiratory volume in 1st second (FEV1)

研究概览

简要总结

To investigate the effects of the addition of motorized movement therapy versus conventional chest physiotherapy alone on pulmonary functions, exercise capacity, and endurance in children with Down Syndrome

详细描述

To investigate the effects of the addition of motorized movement therapy versus conventional chest physiotherapy alone on pulmonary functions, exercise capacity, and endurance in children with Down Syndrome (DS). Methods: This randomized controlled study included 40 children (24 boys & 16 girls) with DS. Their ages ranged from 9 to 13 years. The control group received conventional chest physical therapy program, three sessions per week for 12 weeks. The study group received an aerobic exercise regimen using a motorized movement therapy device 3 times /week in addition to the same traditional program used with the control group. Pulmonary function tests, and six-minutes walking test were measured at baseline, after 18 sessions and after 36 sessions of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
9 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Ability to walk independently
  • No involvement in any physical rehabilitation program or sports activity
  • Ability to understand and follow orders

排除标准

  • Children suffering from obesity
  • Severe visual and/or auditory impairment
  • Congenital heart disease
  • Children with musculoskeletal disorders

结局指标

主要结局

Change from baseline in forced expiratory volume in 1st second (FEV1)

时间窗: Baseline, week 6 and week 12

FEV1 is the maximal volume of air that can be expired in 1st second of forced vital capacity maneuver using spirometry. We measured FEV1 at baseline and at end of 18 sessions (week 6) and 36 sessions (week 12).

Change from baseline in forced vital capacity (FVC)

时间窗: Baseline, week 6 and week 12

Forced vital capacity (FVC) is the maximal volume of air that can be expired while patient performs forced expiration as fast and as deep as possible using spirometry. We measured FVC at baseline and at end of 18 sessions (week 6) and 36 sessions (week 12).

Change from baseline in peak expiratory flow rate (PEFR).

时间窗: Baseline, week 6 and week 12

Peak expiratory flow rate (PEFR).is the maximal flow rate achieved during FVC maneuver using spirometry. We measured PEFR at baseline and at end of 18 sessions (week 6) and 36 sessions (week 12).

Change from baseline in maximum voluntary ventilation (MVV)

时间窗: Baseline, week 6 and week 12

maximum voluntary ventilation (MVV) is the maximal volume of air that can be moved by voluntary ventilation in 1 minute while the patient breathes deeply and rapidly for 12 to 15 seconds using spirometry. We measured MVV at baseline and at end of 18 sessions (week 6) and 36 sessions (week 12).

Change from baseline in FEV1/FVC ratio

时间窗: Baseline, week 6 and week 12

FEV1/FVC is used to differentiate obstructive from restrictive patterns by spirometry. We measuredFEV1/ FVC at baseline and at end of 18 sessions (week 6) and 36 sessions (week 12).

次要结局

  • Six-minutes walking test(Week 1,6 and 12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hatem Abd Elmohsen Abdel Hamid Emara

Associate professor

Taibah University

研究点 (1)

Loading locations...

相似试验